Independent, source-led professional learningClinical content is date-stamped and reviewed
Account access is temporarily restricted.
The public website remains available while sign-in is limited to authorised staff.

Frailty & Clinical Frailty Scale

Managing frailty: from identification to intervention

Translate frailty recognition into an individualised management plan. Prioritise reversible contributors, function, medicines, nutrition, mobility and patient goals.

Clinical safety: Use current guidance, local policy and patient-specific judgement.

Learning objectives

• Translate frailty recognition into an individualised management plan. • Prioritise reversible contributors, function, medicines, nutrition, mobility and patient goals. • Explain the role of multicomponent exercise and rehabilitation without overgeneralising trial protocols. • Use CGA as the organising intervention for complex frailty.

Section 1

Learner handbook (PDF)

Open source ↗

Section 2

Frailty is modifiable, but not with one treatment

Frailty is not a single disease with a single prescription. Management combines treatment of acute and chronic illness with rehabilitation, medicines optimisation, nutrition, falls prevention, sensory support, social intervention and goal-based care. The balance depends on the person’s priorities and the drivers of vulnerability.

Section 3

Treat the trigger and protect function

During acute illness, prevent avoidable secondary decline: unnecessary bed rest, poorly controlled pain, sleep disruption, constipation, dehydration, missed hearing aids, sedating medicines and fragmented handover can all worsen function. Early mobilisation and rehabilitation should be tailored to safety and baseline ability.

Section 4

Exercise and rehabilitation evidence

Recent systematic reviews support multicomponent exercise for improving frailty-related and physical-function outcomes in selected older adults. The evidence does not justify one universal dose or programme. Assessment, contraindications, preferences, setting and professional input matter. The teaching message is that physical function can improve and should be actively considered rather than assumed irreversible.

Section 5

Medicines and treatment burden

Medication review should ask not only whether each medicine has an indication but whether the overall regimen remains proportionate to goals, renal function, falls risk, cognition, adherence and treatment burden. Deprescribing is not simply reducing tablet count; it is structured optimisation with monitoring.

Section 6

Nutrition and oral health

Weight loss, swallowing difficulty, poor dentition, depression, social isolation and acute illness can all reduce intake. Nutrition assessment belongs alongside function and goals. Supplements may be appropriate in selected circumstances, but the course should avoid implying that supplements alone reverse frailty.

Section 7

CGA as the organising process

For complex frailty, CGA provides the structure to connect medical, psychological, functional, social, environmental and future-wishes domains into one prioritised plan. The companion CGA course teaches this in depth. Here the key principle is that intervention follows the person’s problems and goals, not the frailty score itself.

Section 8

Review trajectory

A plan needs a review question: what are we trying to improve, preserve or clarify, and by when? Function, symptom burden, falls, medication burden, carer strain and achievement of personal goals can all be meaningful outcomes.

Section 9

Reflection prompt

What will you do differently when you next assess an older person whose current function differs from their usual baseline? Record one specific change in history-taking, documentation, tool use or multidisciplinary communication.

© 2026 Clinical EducationWebsite is a project by SAS Doctors · sasdoctors.com · editor@clinicaledu.ukVisitors today: 4Protected by Cloudflare